Hospital Universitario and Josep Carreras develop cell therapy for leukaemia
Pharmaceutical Technology
JANUARY 17, 2023
It could be used for T-Cell Acute Lymphoblastic Leukaemia (T-ALL) treatment in patients for whom bone marrow transplantation and chemotherapy failed to work. CAR-T therapies are based on the patient’s immune cell modification and can express artificial chimeric receptors that can identify and remove tumour cells.
Let's personalize your content